This cost analysis assesses Medicare and patient out-of-pocket costs for topical steroids and models potential savings that could result from substitution of the least expensive topical steroid from the corresponding potency class.
http://ift.tt/2p63Qby
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου